New Cancer Drug
ActiveRegistered as Syntherix Limited
Data to 4 Nov 2026, 01:03
- Company number
- 14453188
- Sector
- Health and life sciences
- SIC group
- Life sciences and health
- Region
- East of England (Cambridge)
- Incorporated
- 31 Oct 2022
- SIC code
- 72110
- Trading name
- New Cancer Drug
- Website
- syntherix.co.uk Legal name and address on the site, checked 25 Oct 2026
New Cancer Drug has 1 priced round on record from share allotment filings at Companies House. The latest was allotted on 24 Dec 2024, raised £385k, and was filed on 24 Dec 2024. Data to 3 Nov 2026.
1
Priced rounds
Allotted Dec 2024
£385k
Cash raised in those rounds
Sum of sterling cash raised in each round, as filed
24 Dec 2024
Latest round allotted
Filed 24 Dec 2024
Jump to
Funding rounds
Priced equity rounds read from share allotment filings at Companies House, newest first.
| Allotted | First filed | Cash raised | Filing |
|---|---|---|---|
| 24 Dec 2024to 27 Dec 2024Latest | 24 Dec 2024 | £385k | Open filing |
Companies with significant control
Companies with significant control over New Cancer Drug, from the register of people with significant control. A company can have control without holding shares. Individuals are not shown on public pages.
No corporate holder of 25% or more is registered.
From the PSC register.
Filings
The latest 2 capital filings other than share allotments (SH01), which are listed under Funding rounds. 5 share filings (SH01 and SH02) have been read for this company.
| Date | Filing | Document |
|---|---|---|
| 26 Sep 2023 | Resolution | Open at Companies House |
| 7 Sep 2023 | Subdivision or consolidation of shares (SH02) | Open at Companies House |
Documents open at Companies House. Bradshaw does not store or re-host them.
About this page
This page shows public register data for New Cancer Drug. Figures come from filings at Companies House; Bradshaw links to each filing and does not host copies. To correct or object to data about you, use the data request form.
Last updated 3 Nov 2026